The relationship between renal dysfunction and the severity of coronary artery disease (CAD) was examined.
t is well established that decreased renal function is associated with an increased frequency of cardiovascular disease, so patients with end-stage renal disease have a very high risk for cardiovascular events. However, this is the case even in patients with mildly reduced renal function. In fact, Go et al reported that among the American population patients with mild chronic kidney disease (CKD), such as those whose glomerular filtration rate (GFR) is between 45 and 59 ml · min -1 · 1.73 m −2 , already showed substantial increases in the frequency of cardiovascular events. 1 This has been confirmed not only in population-based epidemiological studies, but also in clinical trials. 2-6 However, the mechanisms of the involvement of renal dysfunction in the occurrence of cardiovascular events remain unclear, although several possibilities have been suggested. It is also unclear which cardiovascular events are likely to occur in patients with renal damage. According to previous reports, coronary artery disease (CAD), including acute myocardial infarction (AMI), is the most frequent type of cardiovascular event in patients with CKD. 3-6 Furthermore, the prognosis of such patients is worse than in those without CKD. 1,2 A Japanese population study recently showed that the risk of cardiovascular events increased as renal function decreased. 7 In that study the leading etiology of the cardiovascular events was cerebral vascular accidents rather than CAD. In Asian countries, particularly in Japan, the occurrence of stroke is twice that of CAD. 8 Nonetheless, the prevalence of AMI is higher in patients with decreased renal function. 7 In the present study, we explored the relationship between renal dysfunction and the severity of CAD by counting the number of stenotic coronary arteries in Japanese patients. Furthermore, as cardiovascular damage has been suggested to aggravate renal dysfunction, 9-11 we followed patients with CAD for 3 years to examine the influence of CAD on renal function.
Methods
For this study, data from 572 consecutive Japanese patients who underwent scheduled coronary angiography (CAG) at the University of Tokyo Hospital under the suspected diagnosis of CAD from August 1999 to February 2004 were analyzed retrospectively.
Scheduled CAG was performed using a transradial, trans-
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brachial or transfemoral approach. All angiographic reports were reviewed by at least 2 operators. The severity of coronary artery stenosis was assessed in the worst view projection and the percentage of luminal narrowing was recorded according to the American Heart Association criteria. 12 Luminal narrowing >51% was considered as significant stenosis. The left anterior descending, left circumflex and right coronary arteries were evaluated, and the number of stenotic arteries was recorded (0 to 3-vessel disease (VD)). A significant stenosis in the left main trunk was scored as 2VD.
Patients were admitted 1-3 days before the day CAG was to be performed. Body weight and blood pressure were measured in the morning of the day of admission. Blood samples were obtained from the antecubital vein, while the patient was supine, in the morning after an overnight fast. The plasma B-type natriuretic peptide (BNP) concentration was measured by enzymatic immunoassay, 13 and that of serum creatinine (Cr) by an enzymatic method using a standard autoanalyzer.
Echocardiographic parameters were measured within 1 month after diagnostic CAG. The left ventricular (LV) dimension was measured on the long-axis view of the left ventricle taken with the patient in the left lateral position. LV ejection fraction (LVEF) was obtained by the following formula: LVEF = (LV end-diastolic volume − end-systolic volume)/LV end-diastolic volume. To evaluate cardiovascular risk factors, the numbers of smokers and patients with hypertension, diabetes mellitus or dyslipidemia were determined. Hypertension was defined as blood pressure >140/90 mmHg or use of antihypertensive agents; diabetes mellitus by fasting blood glucose ≥126 mg/dl or use of hypoglycemic agents or insulin; dyslipidemia by low-density lipoprotein cholesterol level ≥140 mg/dl, high-density lipoprotein cholesterol level ≤40 mg/dl or use of lipid lowering agents; and smoking by present or past smoking.
The patients were divided into 3 groups according to their estimated GFR (eGFR) calculated by the Modification of All study subjects visited hospital regularly as outpatients after discharge. eGFR was monitored for 3 years after diagnostic CAG. To evaluate the effect of contrast media admin- 
istered during CAG or percutaneous coronary intervention (PCI), the frequency of exposure of each patient to contrast media during those 3 years was recorded.
Statistical Analysis
Values are expressed as the mean ± SE. Statistical analyses were performed using SPSS version 17.0 (Chicago, IL, USA). Unpaired Student's t-test was used for comparisons between 2 groups. Tukey's multiple comparison of means following ANOVA was used for comparisons among more than 2 groups. A multiple linear regression analysis of independent predictors of renal prognosis was also performed. The level of statistical significance was set at P<0.05.
Results
The baseline eGFR of the 572 patients showed a normal distribution (Figure 1) , and the mean was 72.1±0.9 ml · min -1 · 1.73 m −2 (median, 71.7; interquartile range, 58.0-84.7). There were 173 (30.2%) patients with a normal eGFR, 238 (41.6%) with a mildly reduced eGFR, and 161 (28.1%) with CKD.
The clinical profile of the patients in each group is shown in Table 1 . Although CKD patients were slightly older than those in the other groups and had decreased renal function, the prevalence of risk factors for CAD was similar among the 3 groups.
As for the severity of CAD, 151 patients (26.4%) had 1VD, 145 (25.3%) had 2VD and 123 (21.5%) had 3VD (Figure 2a) . No significant stenotic lesions were detected in 153 (26.3%) patients. The percentages of patients with multivessel stenosis (2VD+3VD) were significantly greater in the CKD group (P<0.001). The CKD group had a significantly higher number of stenotic coronary arteries then the normal and the mild reduction groups (Figure 2b) . Although blood pressure and LVEF did not differ significantly among the 3 groups, the CKD group had a significantly higher plasma level of BNP than the other 2 groups ( Table 1) .
At the end of the 3-year follow-up eGFR had decreased from 72.1±0.9 to 62.4±0.8 ml · min -1 · 1.73 m −2 (median, 63.4; interquartile range, 50.1-73.9; P<0.001). The rate of decline was 3.2±0.2 ml · min -1 · 1.73 m −2 · year −1 and showed a normal distribution; 79 (13.8%) patients were newly diagnosed with Tables 1, 2 .
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CKD during the follow up. On the other hand, no CKD patient showed improvement of eGFR during the same period. We examined the factors related to the deterioration of renal function. Table 2 compares the clinical background of patients with unchanged renal function (ie, patients included in the upper half of the percent deterioration of eGFR) with that of patients with worsened renal dysfunction (the lower half). Age, systolic blood pressure, prevalence of diabetes mellitus, baseline eGFR, plasma BNP, number of coronary risk factors and number of CAG and PCI during follow-up per patient were found to be significantly higher in the lower half group (ie, the group showing a greater reduction of eGFR). There was no significant difference in the medications nor in the frequency of administration of angiotensin-converting enzyme inhibitors (ACEI) or angiotensin II receptor blockers (ARB) between the 2 groups. The number of stenotic coronary arteries was significantly greater in patients with decreased renal dysfunction compared with patients with unchanged renal function. The percent eGFR deterioration during follow up was significantly higher in the patients whose diagnostic CAG revealed multivessel disease (Figure 3) . Stepwise multiple regression analysis was performed to evaluate the independent determinants of the percent eGFR deterioration ( Table 3) and it was found that the number of stenotic coronary arteries, systolic blood pressure, prevalence of diabetes mellitus, baseline eGFR and plasma BNP, but not the number of CAG and PCI, showed an independent and significant association with the percent eGFR deterioration during follow-up.
Discussion
The incidence of cardiovascular disease increases in patients with reduced renal function. Although the exact mechanisms by which impaired renal function relates to cardiovascular disease remain unclear, many possibilities have been suggested; for example, renal dysfunction activates the reninangiotensin system and sympathetic nervous system, elevates blood pressure, causes anemia and vascular stiffness and calcification, and so on. 16, 17 In the present study, the average number of stenotic coronary arteries was significantly bigger in the CKD group compared with the other 2 groups, which may explain at least in part the poor prognosis of CKD patients. CKD patients were older than patients in the other groups, as reported in previous studies, 1,2,16,17 and this may also have affected the severity of CAD because age has been reported to be a risk factor for CAD. 18 In addition, the CKD group had a significantly higher plasma level of BNP, even though blood pressure and LVEF did not differ among the 3 groups. This finding suggests that patients in the CKD group have a larger cardiac overload, although decreased renal clearance of BNP may explain its high plasma level.
On diagnostic CAG, 26.2% of the patients had CKD. In previous general population studies, 17.5% of subjects in the United States, and 10.3% of subjects in Japan were reported to have CKD. 1, 19 Compared with those reports, the percentage of patients with CKD found in the present study was very high and may be because they already had a substantial number of coronary risk factors. Furthermore, patients in the CKD group were older than those in the other 2 groups.
During follow-up, the eGFR rate of decline was approximately 3 ml · min -1 · 1.73 m −2 · year −1 . Although eGFR is a function of age, 3 years is too short a period to explain this deterioration. eGFR decreases by only 0.1 ml · min -1 · 1.73 m −2 from 60 ml · min -1 · 1.73 m −2 if serum Cr in a patient aged 60 years is 1.0 mg/dl. It has been reported that the eGFR rate of decline is approximately 1 ml · min -1 · 1.73 m −2 · year −1 in Western countries, 20 or 0.36 ml · min -1 · 1.73 m −2 · year −1 in the Japanese general population. 21 Compared with previous data, the patient groups we analyzed had a very poor prognosis regarding renal function. There was no difference between the 2 groups in the usage of ACEI or ARB, which are known to have a renal protective effect. Multivariate analysis showed that the number of stenotic coronary arteries was significantly associated with the percent eGFR deterioration, whereas age, the total number of CAG and PCI during follow-up, and LVEF were not. This finding suggests that CAD can independently affect the prognosis of renal function.
It has been suggested that atherosclerosis causes renal dysfunction. Our study confirms that common mechanisms promote CAD and CKD. O'Hare et al showed that the frequency of increased Cr was significantly higher in those with a reduced ankle-brachial blood pressure index among subjects who participated in the Atherosclerosis Risk in Communities (ARIC) Study. 9 Elsayed et al 10 monitored renal function for 9.3 years on average in subjects from the ARIC Study and the Cardiovascular Health Study. In patients with cardiovascular disease, the odds ratio for worsening of renal failure was significantly high. Furthermore, in the Framingham Heart Study the new onset of renal disease was closely related to the coexistence of coronary risk factors. 11 These findings imply that the presence of atherosclerosis is a risk factor for worsening of renal dysfunction.
Prevalence of diabetes mellitus and a high systolic blood pressure also showed a significant association with reduced eGFR. It has been demonstrated that renal dysfunction worsens more rapidly in diabetic patients 22 and hypertensive patients. 23 Moreover, multivariate analysis revealed a significant relation between baseline eGFR and the rate of reduction in eGFR, which means that the reduction in eGFR in 3 years was greater in patients with a greater baseline eGFR. The reason for this cannot be clarified from the data obtained in the present study. However, it is possible that the decrease in eGFR in diabetic patients in the state of glomerular hyperfiltration may be even greater.
Another possible explanation for the worsening of renal dysfunction in patients with severe CAD is that they may be more exposed to contrast medium. Contrast medium-induced acute kidney injury (AKI) is a serious iatrogenic complication after CAG or PCI. In previous studies, contrast mediuminduced AKI was reported as an increased risk of death or late cardiovascular events. 24,25 CKD, diabetes mellitus, and larger volumes of contrast medium administered in a single procedure were demonstrated to be independent risk factors for contrast medium-induced AKI. 26 There have been no reports regarding whether procedural times of CAG and PCI affect the long-term prognosis of renal dysfunction. However, in the present study contrast medium did not seem to cause the eGFR deterioration observed in the patients with multivessel CAD because the procedural times of CAG and PCI were not independent determinants. We examined the effect of the cumulative amount of contrast media administered in 3 years and did not find a significant relationship between eGFR deterioration and the amount of contrast media (r=0.06, NS, n=318). We could not collect information regarding whether any patient developed AKI after the first CAG or not. AKI itself may have an effect on the longterm prognosis of renal function.
Study Limitations
In the original definition by the K/DOQI, 27 CKD is defined CKD and CAD as GFR <60 ml · min -1 · 1.73 m −2 or having markers of kidney damage even without GFR decrease. Proteinuria has been sometimes referred as a marker of kidney damage, and in the previous studies, proteinuria has been reported to be a possible marker predicting prognosis of renal function. 21 In the present study, we did not include proteinuria in the definition of CKD in order to concentrate on the change in GFR of the patients with CAD over the 3-year period, but this may give some weakness to our data.
There is a common tendency to refrain from catheter examinations of patients with decreased GFR because of the possibility of inducing an acute deterioration by the use of contrast media. This might have brought some bias to the present study because patients with a more severe clinical presentation tended to undergo CAG even if they had decreased GFR. However, the eGFR was normally distributed in the present study, as reported for the Japanese general population, 28 so the bias, if present, may be small.
Conclusion
Patients with CKD have more severe CAD, which may be why there is a high rate of cardiovascular events in CKD patients, that is, the so-called cardiorenal association. Moreover, patients with more severe CAD had a poor prognosis for renal function itself. CAD seemed to be an independent risk factor for worsening of renal dysfunction.
